Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | HPGD | P15428 | 5/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.36 |
| ▸ | NPC1 | O15118 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 5/20 | 0.36 |
| ▸ | LTA4H | P09960 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL275868 | 0.86 | — | — | |
| SCHEMBL21297044 | 0.79 | LTA4H (0.37) | KDM4EALDH1A1L3MBTL1MEN1KMT2A | |
| SCHEMBL7152278 | 0.75 | KDM4E (0.36) | KDM4EALDH1A1HPGDL3MBTL1MAPT | |
| SCHEMBL115447 | 0.72 | CYP3A4 (0.33) | CYP3A4SMN1; SMN2CASP1CASP7 | |
| SCHEMBL8095665 | 0.72 | CYP3A4 (0.52) | KDM4EALDH1A1HPGDL3MBTL1MAPT | |
| SCHEMBL19127624 | 0.72 | MAOA (0.38) | KDM4EALDH1A1HPGDL3MBTL1MAPT | |
| SCHEMBL10854744 | 0.72 | ALDH1A1 (0.41) | KDM4EALDH1A1HPGDL3MBTL1MAPT | |
| SCHEMBL5281380 | 0.72 | MAPT (0.41) | KDM4EALDH1A1HPGDL3MBTL1MAPT | |
| SCHEMBL2779806 | 0.70 | KDM4E (0.43) | KDM4EALDH1A1HPGDL3MBTL1MAPT | |
| SCHEMBL21295790 | 0.70 | PTGS2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 972 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230339852-A1 | DICARBOXYLIC ACID COMPOUNDS, INORGANIC PARTICLES TREATED WITH THE DICARBOXYLIC ACID COMPOUNDS, AND COMPOSITIONS THEREOF | 3M INNOVATIVE PROPERTIES COMPANY | 2023-10-26 | — | — | US | claimed |
| US-11787959-B2 | Radiation curable gravure ink | CHANGZHOU GREEN PHOTOSENSITIVE MATERIALS CO., LTD. (CN) | 2023-10-17 | — | — | US | claimed |
| CN-116730995-A | Hydrazide compound, preparation method and application thereof | 深圳微芯生物科技股份有限公司 | 2023-09-12 | — | — | CN | claimed |
| US-20230220161-A1 | POLYIMIDE PRECURSOR PREPARED BY USING POLYCYCLIC MONOMER INCLUDING TRIFLUOROMETHYL GROUP AND FLEXIBLE POLYIMIDE OBTAINED BY USING THE SAME | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-07-13 | — | — | US | claimed |
| CN-111484541-B | Dinucleotide prodrugs and methods of making same | 博瑞生物医药（苏州）股份有限公司 | 2023-06-02 | — | — | CN | claimed |
| CN-112143284-B | Radiation-curable ink and use thereof | 常州强力电子新材料股份有限公司 | 2022-09-27 | — | — | CN | claimed |
| CN-115043880-A | Nitrogen-antimony-octylepisulfide/selenium derivative and efficient synthesis method thereof | 湖南大学 | 2022-09-13 | — | — | CN | claimed |
| CN-114585604-A | Dicarboxylic acid compound, inorganic particle treated with dicarboxylic acid compound, and composition thereof | 3M创新有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114361341-A | Laminated image pickup device and image pickup module | 索尼公司 | 2022-04-15 | — | — | CN | claimed |
| CN-107534050-B | Image sensor, laminated image pickup device, and image pickup module | 索尼公司 | 2021-12-14 | — | — | CN | claimed |
| EP-0770079-A1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-02 | — | — | EP | claimed |
| WO-1996033170-A1 | N-AROYLAMINO ACID AMIDES AS ENDOTHELIN INHIBITORS | NOVARITS AG (CH) | 1996-10-24 | — | — | WO | claimed |
| EP-0728145-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | Ciba-Geigy Japan Limited (JP) | 1996-08-28 | — | — | EP | claimed |
| US-5532358-A | Method for preparing alkyl-5,11-dihydro-6h-dipyrido[3,2-B:2',3'-E] [1,4] diazepin-6-ones | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1996-07-02 | — | — | US | claimed |
| WO-1996001825-A1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-01-25 | — | — | WO | claimed |
| WO-1995012611-A1 | ENDOTHELIN RECEPTOR ANTAGONISTS | JAPAT LTD. (CH) | 1995-05-11 | — | — | WO | claimed |
| EP-0534582-A1 | Methylation or ethylation agent and process for an 1,4-addition of a methyl- or ethylgroup to an alpha, beta-insaturated ketogroup | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-03-31 | — | — | EP | claimed |
| EP-0111997-A2 | Vinyl carboxylic acid derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1984-06-27 | — | — | EP | claimed |
| US-4178443-A | Derivatives of 7 [-substituted oxyimins acetamido] cephalosporins | HOFFMANN-LA ROCHE INC. (US) | 1979-12-11 | — | — | US | claimed |
| EP-0004134-A1 | Beta-lactam antibacterial agents, their pharmaceutical compositions and process for their preparation | BEECHAM GROUP PLC (GB) | 1979-09-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230339852-A1 | DICARBOXYLIC ACID COMPOUNDS, INORGANIC PARTICLES TREATED WITH THE DICARBOXYLIC ACID COMPOUNDS, AND COMPOSITIONS THEREOF | F12, RCC1, C9 | KDM4E 2190/4885ALDH1A1 2631/4885HPGD 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.